Imeik Technology Development Co.,Ltd.
300896
Κατάταξη σε μετοχές
#3929
Imeik Technology Development Co.,Ltd. specializes in the research, development,... Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
Τιμή μετοχής
$14.36
Κεφαλαιοποίηση
$4.35B
Αλλαγή (1 ημέρα)
0.22%
Αλλαγή (1 έτος)
-39.05%
Χώρα
CN
Εμπόριο Imeik Technology Development Co.,Ltd. (300896)
Κατηγορία
Healthcare
Δείκτης P/S για Imeik Technology Development Co.,Ltd. (300896)
Δείκτης P/S στις October 2026 TTM: 12.08
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Imeik Technology Development Co.,Ltd., ο τρέχων δείκτης P/S (TTM) είναι 12.08. Στο τέλος του 2023, ο δείκτης ήταν 21.54.
Ιστορικό P/S για την Imeik Technology Development Co.,Ltd. από 2014 έως 2026
Δείκτης P/S στο τέλος κάθε έτους
| Έτος | P/S Ratio | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 12.08 | -33.52% |
| 2024 | 18.17 | -15.66% |
| 2023 | 21.54 | -52.29% |
| 2022 | 45.14 | -21.11% |
| 2021 | 57.22 | -27.83% |
| 2020 | 79.29 | 51.44% |
| 2019 | 52.36 | -22.85% |
| 2018 | 67.86 | -31.18% |
| 2017 | 98.61 | -33.64% |
| 2016 | 148.61 | -20.55% |
| 2015 | 187.04 | -32.82% |
| 2014 | 278.39 | 0.00% |
Δείκτης P/S για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | P/S Ratio | Διαφορά P/S Ratio | Χώρα |
|---|---|---|---|
| 13.45 | 11.38% |
US
|
|
| 2.32 | -80.76% |
FR
|
|
| - | - |
JP
|
|
| 2.47 | -79.56% |
US
|
|
| - | - |
CH
|
